Article

Curtis, PJ, Potter, J, Kroon, PA, Wilson, P, Dhatariya, K, Sampson, M and Cassidy, A (2013) Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. The American journal of clinical nutrition, 97 (5). pp. 936-42. ISSN 1938-3207 (In Press)

Curtis, P, Sampson, M, Potter, JF, Dhatariya, K, Kroon, PA and Cassidy, A (2012) Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a one year double-blind randomized controlled trial. Diabetes Care, 35 (2). pp. 226-232. ISSN 0149-5992

Kumaravel, B, Bachmann, MO, Murray, N, Dhatariya, K, Fenech, M, John, WG, Scarpello, TJ and Sampson, MJ (2012) Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population. Diabetes Research and Clinical Practice, 2. pp. 211-216. ISSN 01688227

Scarpello, TJ, Murray, NJ, Maisey, S, Howe, AC and Sampson, MJ (2012) A qualitative assessment of using lay trainers with type 2 diabetes in an intervention programme for people at risk of type 2 diabetes. Health Education Journal. ISSN 0017-8969 (In Press)

Irvine, L, Barton, GR, Gasper, A, Murray, N, Clark, A, Scarpello, T and Sampson, M.J. (2011) Cost effectiveness of a lifestyle intervention in preventing Type 2 diabetes: economic evaluation alongside a clinical trial. International Journal of Technology Assessment in Health Care, 27. pp. 275-282.

Perry, J. R.B., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparso, T., Thorleifsson, G., Grallert, H., Ferrucci, L., Maggio, M., Paolisso, G., Walker, M., Palmer, C. N.A., Payne, F., Young, E., Herder, C., Narisu, N., Morken, M. A., Bonnycastle, L. L., Owen, K. R., Shields, B., Knight, B., Bennett, A., Groves, C. J., Ruokonen, A., Jarvelin, M. R., Pearson, E., Pascoe, L., Ferrannini, E., Bornstein, S. R., Stringham, H. M., Scott, L. J., Kuusisto, J., Nilsson, P., Neptin, M., Gjesing, A. P., Pisinger, C., Lauritzen, T., Sandbaek, A., Sampson, M., Zeggini, M. E., Lindgren, C. M., Steinthorsdottir, V., Thorsteinsdottir, U., Hansen, T., Schwarz, P., Illig, T., Laakso, M., Stefansson, K., Morris, A. D., Groop, L., Pedersen, O., Boehnke, M., Barroso, I., Wareham, N. J., Hattersley, A. T., McCarthy, M. I. and Frayling, T. M. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Human Molecular Genetics, 19 (3). pp. 535-544. ISSN 0964-6906

Saxena, Richa, Hivert, Marie-France, Langenberg, Claudia, Tanaka, Toshiko, Pankow, James S, Vollenweider, Peter, Lyssenko, Valeriya, Bouatia-Naji, Nabila, Dupuis, Josée, Jackson, Anne U, Kao, W H Linda, Li, Man, Glazer, Nicole L, Manning, Alisa K, Luan, Jian'an, Stringham, Heather M, Prokopenko, Inga, Johnson, Toby, Grarup, Niels, Boesgaard, Trine W, Lecoeur, Cécile, Shrader, Peter, O'Connell, Jeffrey, Ingelsson, Erik, Couper, David J, Rice, Kenneth, Song, Kijoung, Andreasen, Camilla H, Dina, Christian, Köttgen, Anna, Le Bacquer, Olivier, Pattou, François, Taneera, Jalal, Steinthorsdottir, Valgerdur, Rybin, Denis, Ardlie, Kristin, Sampson, Michael, Qi, Lu, van Hoek, Mandy, Weedon, Michael N, Aulchenko, Yurii S, Voight, Benjamin F, Grallert, Harald, Balkau, Beverley, Bergman, Richard N, Bielinski, Suzette J, Bonnefond, Amelie, Bonnycastle, Lori L, Borch-Johnsen, Knut, Böttcher, Yvonne, Brunner, Eric, Buchanan, Thomas A, Bumpstead, Suzannah J, Cavalcanti-Proença, Christine, Charpentier, Guillaume, Chen, Yii-Der Ida, Chines, Peter S, Collins, Francis S, Cornelis, Marilyn, J Crawford, Gabriel, Delplanque, Jerome, Doney, Alex, Egan, Josephine M, Erdos, Michael R, Firmann, Mathieu, Forouhi, Nita G, Fox, Caroline S, Goodarzi, Mark O, Graessler, Jürgen, Hingorani, Aroon, Isomaa, Bo, Jørgensen, Torben, Kivimaki, Mika, Kovacs, Peter, Krohn, Knut, Kumari, Meena, Lauritzen, Torsten, Lévy-Marchal, Claire, Mayor, Vladimir, McAteer, Jarred B, Meyre, David, Mitchell, Braxton D, Mohlke, Karen L, Morken, Mario A, Narisu, Narisu, Palmer, Colin N A, Pakyz, Ruth, Pascoe, Laura, Payne, Felicity, Pearson, Daniel, Rathmann, Wolfgang, Sandbaek, Annelli, Sayer, Avan Aihie, Scott, Laura J, Sharp, Stephen J, Sijbrands, Eric, Singleton, Andrew, Siscovick, David S, Smith, Nicholas L, Sparsø, Thomas, Swift, Amy J, Syddall, Holly, Thorleifsson, Gudmar, Tönjes, Anke, Tuomi, Tiinamaija, Tuomilehto, Jaakko, Valle, Timo T, Waeber, Gérard, Walley, Andrew, Waterworth, Dawn M, Zeggini, Eleftheria, Zhao, Jing Hua, Illig, Thomas, Wichmann, H Erich, Wilson, James F, van Duijn, Cornelia, Hu, Frank B, Morris, Andrew D, Frayling, Timothy M, Hattersley, Andrew T, Thorsteinsdottir, Unnur, Stefansson, Kari, Nilsson, Peter, Syvänen, Ann-Christine, Shuldiner, Alan R, Walker, Mark, Bornstein, Stefan R, Schwarz, Peter, Williams, Gordon H, Nathan, David M, Kuusisto, Johanna, Laakso, Markku, Cooper, Cyrus, Marmot, Michael, Ferrucci, Luigi, Mooser, Vincent, Stumvoll, Michael, Loos, Ruth J F, Altshuler, David, Psaty, Bruce M, Rotter, Jerome I, Boerwinkle, Eric, Hansen, Torben, Pedersen, Oluf, Florez, Jose C, McCarthy, Mark I, Boehnke, Michael, Barroso, Inês, Sladek, Robert, Froguel, Philippe, Meigs, James B, Groop, Leif, Wareham, Nicholas J and Watanabe, Richard M (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nature Genetics, 42 (2). pp. 142-148. ISSN 1061-4036

Sampson, MJ, Harvey, IM, Mugford, M and Holland, RC (2007) Assessing Inpatient Diabetes Treatment satisfaction in difference ethnic groups in the UK. Diabetes UK.

Castleden, H, Shields, B, Bingleyy, P, Williams, A, Sampson, MJ, Walker, J, Gibson, JM, McCarthy, MI, Hitman, GA, Levy, JC, Hattersley, AT, Vaidya, B and Pearson, ER (2006) GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes. Diabetic Medicine, 23 (8). pp. 834-838.

Sampson, M., Wall, S., Baugh, M., Worley, J., Davies, I., Hughes, D. and Gavrilovic, J. (2006) Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy. Diabetes Research and Clinical Practice, 71. pp. 45-51.

Sampson, MJ and Hughes, D (2006) Chromosomal telomere attrition as mechanisms for increased risk of cancer and senescent phenotypes in Type 2 Diabetes. Diabetologia, 49 (8). pp. 1726-1732.

Sampson, MJ, Winterbone, MS, Hughes, JC, Dozio, N and Hughes, DA (2006) Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care, 29 (2). pp. 283-289.

Sampson, MJ, Barrie, P, Dozio, N, Flatman, M, Hadley-Brown, M, Harvey, IM, Heyburn, PJ, Jones, C, Mann, R, Temple, RC and Greenwood, RH (2005) A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care. Diabetic Medicine, 22 (3). pp. 256-257.

Sampson, MJ, Braschi, S, Willis, G and Astley, SB (2005) Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes. Clinical Science, 109 (2). pp. 189-197.

Zeggini, E, Parkinson, JR, Halford, S, Owen, KR, Walker, M, Hitman, GA, Levy, JC, Sampson, MJ, Frayling, TM, Hattersley, AT and McCarthy, MI (2005) Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples. Diabetic Medicine, 22 (12). pp. 1696-1700.

Mills, GW, Avery, PJ, McCarthy, MI, Hattersley, AT, Levy, JC, Hitman, GA, Sampson, MJ and Walker, M (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia, 47 (4). pp. 732-738.

Sampson, M.J., Davies, I., Gavrilovic, J., Sussams, B., Brown, J., Astley, S.B. and Hughes, D.A. (2004) Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes. Cardiovascular Diabetology, 3. p. 7.

Wiltshire, S, Frayling, TM, Groves, CJ, Levy, JC, Hitman, GA, Sampson, MJ, Walker, M, Menzel, S, Hattersley, AT, Cardon, LR and McCarthy, MI (2004) Evidence from a large U.K. family collection that genes influencing age of onset of type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24. Diabetes, 53 (3). pp. 855-860.

Zeggini, E, Parkinson, J, Halford, S, Owen, KR, Frayling, TM, Walker, M, Hitman, GA, Levy, JC, Sampson, MJ, Feskens, EJ, Hattersley, AT and McCarthy, MI (2004) Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset. Diabetes, 53 (12). pp. 3319-3322.

Baugh, M.D., Gavrilovic, J., Davies, I.R., Hughes, D.A. and Sampson, M.J. (2003) Monocyte matrix metalloproteinase production in Type 2 diabetes and controls - a cross sectional study. Cardiovasc Diabetol, 2. pp. 1-4.

Frayling, TM, Wiltshire, S, Hitman, GA, Walker, M, Levy, JC, Sampson, MJ, Groves, CJ, Menzel, S, McCarthy, MI and Hattersley, AT (2003) Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. Diabetes, 52 (7). pp. 1857-1863.

Gloyn, AL, Weedon, MN, Owen, KR, Turner, MJ, Knight, BA, Hitman, G, Walker, M, Levy, JC, Sampson, MJ, Halford, S, McCarthy, MI, Hattersley, AT and Frayling, TM (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes, 52 (2). pp. 568-572.

Sampson, MJ, Davies, I, Braschi, S, Hughes, D and Ivory, K (2003) Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis, 167 (1). pp. 129-134.

Wall, S.J., Sampson, M.J., Levell, N. and Murphy, G. (2003) Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. British Journal of Dermatology, 149. pp. 13-16.

Weedon, MN, Schwarz, PE, Horikawa, Y, Iwasaki, N, Illig, T, Holle, R, Rathmann, W, Selisko, T, Schulz, J, Owen, KR, Evans, J, Del Bosque-Plata, L, Hitman, G, Walker, M, Levy, JC, Sampson, MJ, Bell, GI and McCarthy, MI (2003) Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. American Journal of Human Genetics, 73 (5). pp. 1208-1212.

Sampson, MJ, Davies, IR, Brown, JC, Ivory, K, Hughes, DA, Linseisen, J, Ocke, MC and Bueno-de-Mesquita, B (2002) Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol, 22 (7). pp. 1187-1193.

Sampson, MJ, Gopaul, N, Davies, IR, Hughes, DA and Carrier, MJ (2002) Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care, 25 (3). pp. 537-541.

Sampson, MJ, Greenwood, R, Harvey, IM, Heyburn, P, Shepstone, L, Temple, R and Dole, D (2002) Detection of 'at risk' feet in 4022 patients with Type 2 diabetes managed solely in primary care. Diabetic Medicine, 101. pp. 235-241.

Sampson, MJ, Shepstone, L, Greenwood, RH, Harvey, IM, Humphries, J, Heyburn, PJ, Temple, RC and Dole, G (2002) An integrated mobile foot and retinal screening programme for people with Type 2 diabetes managed in primary care. Diabetic Medicine, 19 (1). pp. 74-76.

Temple, R, Aldridge, VA, Greenwood, R, Heyburn, P, Sampson, MJ and Stanley, K (2002) Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. British Medical Journal, 325 (7375). pp. 1275-1276.

Sampson, MJ, Davies, IR, Brown, JC, Morgan, V, Richardson, T, James, AJ, Sampson, AP and Hughes, DA (2001) n-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in Type 2 diabetes mellitus. Diabetic Medicine, 18 (1). pp. 51-58.

Sampson, MJ, Wright, DJ, Richardson, T, Astley, SB and Southon, S (2001) Alpha - tocopherol supplementation, oxidative DNA and lipoprotein damage in Type 2 diabetes. Clinical Science, 18. pp. 51-58.

Temple, RC, Aldridge, VA, Sampson, MJ, Greenwood, RH, Heyburn, PJ and Glenn, A (2001) Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabetic Medicine, 18 (7). pp. 573-577.

Wiltshire, S, Hattersley, AT, Hitman, GA, Walker, M, Levy, JC, Sampson, MJ, O'Rahilly, S, Frayling, TM, Bell, JI, Lathrop, GM, Bennett, A, Dhillon, R, Fletcher, C, Groves, CJ, Jones, E, Prestwich, P, Simecek, N and Rao, PV (2001) A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. American Journal of Human Genetics, 69 (3). pp. 553-569.

Murray, N, Abadi, S, Blain, A, Dunk, M, Sampson, M and Barton, G The importance of type 2 diabetes prevention: The Norfolk Diabetes Prevention Study. The British Journal of Diabetes and Vascular Disease. (In Press)

Sampson, MJ, Crowle, T, Dhatariya, K, Dozio, N, Heyburn, P and et, a Excess diabetes bed occupancy in 152,080 discharges from a single UK Hospital and all English Acute Trusts - impact of a diabetes inpatient specialist nurse service. Diabetic Medicine. (In Press)

Singh, R, Pearson, E, Avery, PJ, McCarthy, M, Levy, J, Hitman, G, Sampson, MJ, Walker, M and AT, H Reduced b-cell function in offspring of mothers with young-onset type 2 diabetes. Diabetologia. (In Press)